Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto (rivaroxaban) and suffered critical bleeding events. Pharmaceutical companies, like the makers of Xarelto, possess a duty to ensure that their drugs are reasonably safe for use - and failure to complete so may possibly be grounds for compensation. Our lawyers are operating challenging to have these hurt by the drug the compensation they are entitled to.<br><br> <br><br> Although bleeding is really a widespread complication connected with anticoagulants, it has been alleged that Xarelto is far more unsafe than conventional blood - http://en.wiktionary.org/wiki/conventional%20blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This means that, within the occasion of an emergency, patients could be at risk for irreversible bleeding difficulties, such as life-threatening internal and gastrointestinal hemorrhaging.<br><br> <br><br> In case you or even a loved 1 suffered - http://Www.Wordreference.com/definition/suffered a critical bleeding occasion right after taking Xarelto, you might have legal recourse. For a lot more information, get in touch with us right now to have your case reviewed, cost-free of charge.<br><br> Compensation Possibilities<br><br> <br><br> xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for previous and future health-related bills, lost wages, discomfort and suffering and, in circumstances of death, funeral expenses. In addition, they're seeking punitive damages, that are normally awarded to punish the defendant and deter other firms from acting similarly.<br><br> Why Are Lawsuits Being Filed?<br><br> <br><br> Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike conventional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding within the occasion of an emergency. Plaintiffs within the lawsuits allege serious and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.<br><br> <br><br> In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:<br><br> <br><br> The manufacturers of Xarelto marketed the drug as a superior in the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.<br><br> The makers of the drug continue to market Xarelto as a safe anticoagulant option.<br><br> Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user in the event of a bleeding complication.<br><br> Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.<br><br> Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing harmful clotting.<br><br> <br><br> Visit this page for much more information on the alleged health risks of Xarelto.<br><br> Multidistrict Litigation http://xareltolegalline.bitbucket.org/categories/Pennsylvania/Xarelto-Gi-Bleed-Mount-Joy-PA-17552.html - http://xareltolegalline.bitbucket.org/categories/Pennsylvania/Xarelto-Gi-Bleed-Mount-Joy-PA-17552.html Trial Dates Set<br><br> <br><br> The attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.